3Odmark IS, Backstrom T. Effects of continuous combined conjugated estrogen/medroxyprogesterone acetate and 17beta-estadiol/norethisterone acetate on lipids and lipoproteins. Maturitas 2004;48 (2):137-46.
4Chang TC, Lien YR. Effect of conjugated equine estrogen in combination with two different progestogens on the risk factors of coronary heart disease in postmenopausal Chinese women in Taiwan: a randomized one-year study. Acta Obstet Gynecol Scand 2004; 83(7): 661-6.
5Alper T, Cetinkaya MB, Kokcu A, et al. Do lipid profiles of postmenopausal women under oral hormone replacement therapy remain stable or reveal a multiphasic course in time? Gynecol Endocrinol 2004; 18 (4): 199-205.
6Lamon-Fava S, Posfai B, Asztalos BF, et al. Effects of estrogen and medroxyprogesterone acetate on subpopulations of triglyceride-rich lipoproteins and highdensity lipoproteins. Metabolism 2003;52 (10): 1330-6.
7Ritsch A, Kaser S, Volgger B, et al. Enhancement of cholesteryl ester transfer in plasma by hormone-replacemert therapy. Metabolism 2002; 51 (5): 599-604.
8Patrono C,Bachmann F,Baigent C,et al.European Society of Cardiology.Expert consensus document on the use of antiplatelet agents.The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology.Eur Heart J,2004,25:166-181.
9Eagle KA,Guyton RA,Davidoff R,et al.American College of Cardiology.American Heart Association Task Force on Practice Guidelines.American Society for Thoracic Surgery and the Society of Thoracic Surgeons.ACC/AHA 2004 guideline update for coronary artery bypass graft surgery:summary article:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery).Circulation,2004,110:1168-1176.
10Stein PD,Alpert JS,Bussey HI,et al.Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves.Chest,2001,119:2205-2275.
